Tsumura & 4540.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4540.T. It has been listed since 21 November 1980. In the fiscal year to 31 March 2026, it reported revenue of ¥192.62bn and net income of ¥28.12bn. At that date it held total assets of ¥592.77bn and shareholders' equity of ¥321.73bn.

Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Minato-Ku, Tokyo-To. Through its subsidiaries, the Company is also engaged in the procurement, sorting and processing of crude drugs, the manufacture and sale of Chinese herbal extract powders and drug substances, the operation of dispensing pharmacies and the provision of logistics services, as well as the development of pharmaceuticals.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Terukazu KatoPresident, Chief Executive Officer, Representative Director, since 2011¥139.0m
• Mr. Muneki HandaChief Financial Officer, Director, since 2019
• Mr. Kei SugiiCo-Chief Operating Officer, Director, since 2020
• Mr. Koin TodaCo-Chief Operating Officer
• Mr. Susumu AdachiChief Human Resource Officer, since 2017
• Mr. Yukinori SorataExecutive Officer, Chief Director of Pharmaceutical Sales
• Mr. Tadahiro AbeExecutive Officer, Chief Director of Healthcare
• Mr. Koji EndoExecutive Officer, Manager of Tsumara Academy
• Mr. Akihito KondaExecutive Officer, Chief Director of Research & Development
• Mr. Shoichi KumagaiExecutive Officer, Chief Director of Production
• Mr. Kazushige MizoguchiExecutive Officer, Chief Director of Reliability Assurance
• Mr. Kouji ShisekiExecutive Officer, Director of Legal and Compliance

Overall

67

Environment

58

Social

60

Governance

83

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.